c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• Mycobacterium tuberculosis (MTB) causes significant global mortality.
• Innate immunity, particularly interferon gamma (IFN-γ), is crucial for controlling MTB infection.
• Understanding the timing of immune responses is vital for effective host-directed therapies.

Purpose of the Study:

• To investigate the impact of IFN-γ timing on macrophage-mediated control of MTB.
• To identify key molecular regulators of macrophage antimycobacterial activity.
• To explore c-Myc signaling as a potential therapeutic target for tuberculosis.

Main Methods:

• In vitro systems approaches to analyze macrophage responses to MTB.
• Development of a tetracycline-inducible lentiviral system for c-Myc manipulation.
• Murine models and human clinical histopathology for in vivo validation.

Main Results:

• Pre-infection IFN-γ exposure enhances macrophage bacterial control, while post-infection exposure does not.
• c-Myc signaling was identified as a central determinant of macrophage antimycobacterial function.
• Inhibition of c-Myc (via Omomyc) improved bacterial control through mTORC1-dependent pathways and nitric oxide production.
• In vivo studies linked c-Myc expression to MTB persistence and active tuberculosis.

Conclusions:

• The timing of IFN-γ exposure critically influences macrophage efficacy against MTB.
• c-Myc signaling plays a significant role in MTB immune evasion and disease progression.
• Targeting c-Myc represents a promising strategy for host-directed therapies against tuberculosis.